By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Amarillo Biosciences Inc. 

4134 Business Park Dr

Amarillo  Texas  79110  U.S.A.
Phone: 806-376-1741 Fax: 806-376-9301




Company News
Amarillo Biosciences (AMAR) Announces Presentation Of Eltoprazine Phase I/IIa Clinical Data At The 19th International Congress Of Parkinson's Disease And Movement Disorders 6/15/2015 8:56:50 AM
Amarillo Biosciences (AMAR) Summarizes New Plan After Filing For Banruptcy In January 5/18/2015 12:00:01 PM
Amarillo Biosciences (AMAR) Initiates CLIA Development Of Alzheimer's Blood Diagnostic Lympro Test® At ICON Central Laboratories 9/2/2014 8:06:47 AM
Amarillo Biosciences (AMAR) Exercises Option To License Intellectual Property From University Of Miami Bascom Palmer Eye Institute For Use Of MANF In Retinal Disorders 8/15/2014 7:54:40 AM
Amarillo Biosciences (AMAR) And BSI Proudly Announce Biotechnology Industry Organization (BIO) CEO & President Jim Greenwood As Panelist For 3rd Alzheimer's Focused #C4CT Concussion Awareness Summit At United Nations 7/22/2014 3:52:26 PM
Amarillo Biosciences (AMAR) Announces Positive Analytical Performance Data Poster Presentation For Lympro Test At AAIC 2014 7/14/2014 7:55:47 AM
Amarillo Biosciences (AMAR) Appoints Dr. Charlotte Keywood Chief Medical Officer Of Its Therapeutics Division 4/8/2014 1:50:19 PM
Amarillo Biosciences (AMAR) Announces Plan to Open Asia Operations Center in Taipei, Taiwan 6/26/2012 9:10:39 AM
CytoPharm and Amarillo Biosciences (AMAR) Announce Positive HCV Study Results: Oral Interferon Found to Reverse Thrombocytopenia; Reduced Relapse Rate Seen in Patients With Mild Fibrosis 6/15/2012 7:50:48 AM
Amarillo Biosciences (AMAR) Appoints Dr. Stephen Chen as Chairman and CEO 2/23/2012 7:31:29 AM